Cargando…

The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy

Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy...

Descripción completa

Detalles Bibliográficos
Autores principales: Pyromali, Ioanna, Richard, Laurence, Derouault, Paco, Vallat, Jean-Michel, Ghorab, Karima, Magdelaine, Corinne, Sturtz, Franck, Favreau, Frédéric, Lia, Anne-Sophie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295399/
https://www.ncbi.nlm.nih.gov/pubmed/37371660
http://dx.doi.org/10.3390/biomedicines11061565
_version_ 1785063411322716160
author Pyromali, Ioanna
Richard, Laurence
Derouault, Paco
Vallat, Jean-Michel
Ghorab, Karima
Magdelaine, Corinne
Sturtz, Franck
Favreau, Frédéric
Lia, Anne-Sophie
author_facet Pyromali, Ioanna
Richard, Laurence
Derouault, Paco
Vallat, Jean-Michel
Ghorab, Karima
Magdelaine, Corinne
Sturtz, Franck
Favreau, Frédéric
Lia, Anne-Sophie
author_sort Pyromali, Ioanna
collection PubMed
description Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy symptoms using the CovCopCan bioinformatic tool, we discovered the presence of a deletion of around 3kb in ATL3 from Chr11:63,401,422 to Chr11:63,398,182. This deletion affects ATL3 exons 11 and 12 and could lead to the mutation c.(1036-861_1539+329del), p.(Ala346_Gln513del). In addition, an analysis of the breakpoints’ sequences revealed the presence of Alu transposable elements at the position of the breakpoints, which pointed to a possible erroneous recombination event following a non-allelic-homologous-recombination mechanism in this area. Moreover, electronic microscopy analysis of the patient’s nerve biopsy revealed a severe rarefaction of the myelinated fibers, a demyelinating–remyelinating process, and an abnormal aspect of the endoplasmic reticulum. These findings suggest that this structural variation could potentially be responsible for the HSN symptoms of the patient. Research of structural variations in ATL3 in numerous other patients presenting similar symptoms should be broadly investigated in order to improve patients’ diagnoses.
format Online
Article
Text
id pubmed-10295399
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102953992023-06-28 The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy Pyromali, Ioanna Richard, Laurence Derouault, Paco Vallat, Jean-Michel Ghorab, Karima Magdelaine, Corinne Sturtz, Franck Favreau, Frédéric Lia, Anne-Sophie Biomedicines Article Hereditary sensory neuropathies (HSN) are a heterogenous group of sensory neuropathies. Mutations in ATL3 have been described in patients presenting with hereditary sensory neuropathy IF (HSN1F), a subtype of HSN. Herein, by analyzing targeted-NGS data of a patient presenting with sensory neuropathy symptoms using the CovCopCan bioinformatic tool, we discovered the presence of a deletion of around 3kb in ATL3 from Chr11:63,401,422 to Chr11:63,398,182. This deletion affects ATL3 exons 11 and 12 and could lead to the mutation c.(1036-861_1539+329del), p.(Ala346_Gln513del). In addition, an analysis of the breakpoints’ sequences revealed the presence of Alu transposable elements at the position of the breakpoints, which pointed to a possible erroneous recombination event following a non-allelic-homologous-recombination mechanism in this area. Moreover, electronic microscopy analysis of the patient’s nerve biopsy revealed a severe rarefaction of the myelinated fibers, a demyelinating–remyelinating process, and an abnormal aspect of the endoplasmic reticulum. These findings suggest that this structural variation could potentially be responsible for the HSN symptoms of the patient. Research of structural variations in ATL3 in numerous other patients presenting similar symptoms should be broadly investigated in order to improve patients’ diagnoses. MDPI 2023-05-28 /pmc/articles/PMC10295399/ /pubmed/37371660 http://dx.doi.org/10.3390/biomedicines11061565 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pyromali, Ioanna
Richard, Laurence
Derouault, Paco
Vallat, Jean-Michel
Ghorab, Karima
Magdelaine, Corinne
Sturtz, Franck
Favreau, Frédéric
Lia, Anne-Sophie
The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title_full The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title_fullStr The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title_full_unstemmed The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title_short The First Large Deletion of ATL3 Identified in a Patient Presenting with a Sensory Polyneuropathy
title_sort first large deletion of atl3 identified in a patient presenting with a sensory polyneuropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295399/
https://www.ncbi.nlm.nih.gov/pubmed/37371660
http://dx.doi.org/10.3390/biomedicines11061565
work_keys_str_mv AT pyromaliioanna thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT richardlaurence thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT derouaultpaco thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT vallatjeanmichel thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT ghorabkarima thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT magdelainecorinne thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT sturtzfranck thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT favreaufrederic thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT liaannesophie thefirstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT pyromaliioanna firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT richardlaurence firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT derouaultpaco firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT vallatjeanmichel firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT ghorabkarima firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT magdelainecorinne firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT sturtzfranck firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT favreaufrederic firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy
AT liaannesophie firstlargedeletionofatl3identifiedinapatientpresentingwithasensorypolyneuropathy